National Research Corporation

NRC Healthcare Health Information Services

National Research Corporation’s revenue for fiscal 2025 (year ended December 2025) was $137.4 million, down 3.96% from fiscal 2024. In the quarter to June 2026, revenue grew 3.98%, EPS fell 3,091.5%, free cash flow grew 101.5% and total debt rose 11.7%, each against the same quarter a year earlier. Dividend growth for three consecutive years; insiders bought in the last twelve months.

20.15 0.96 −4.55%
Market cap
$466.9M
P/E
80.6×
Fwd P/E
4.9×
Dividend yield
3.18%
F-score
6/9
Altman Z
3.33
Beneish M
−3.10
Dividend safety
45/100
Older periods Sep '25 Dec '25 Mar '26 Jun '26
ROE

+8 more TTM periods

66.87% 49.88% 40.43% 39.82%
Piotroski F-Score
6 6 5 5
ROA
12.23% 8.45% 6.47% 4.00%
ROIC
19.51% 16.64% 14.39% 10.32%
Return on Tangible Assets
70.38% 46.93% 40.00% 20.34%
Average Days of Receivables
33.45 30.91 29.79 35.59
Free Cash Flow per Share
0.53 0.70 0.80 0.98
Free Cash Flow
11.62 15.74 17.43 21.64
Other line items

Show all line items

Columns are period end dates